Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $4.6550 (1.86%) ($4.6550 - $4.6600) on Wed. Nov. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.51% (three month average) | RSI | 25 | Latest Price | $4.6550(1.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -15.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(82%) ARKG(79%) ARKK(77%) IBUY(75%) IWO(75%) | Factors Impacting CGEN price | CGEN will decline at least -2.255% in a week (0% probabilities). VIXM(-58%) VXX(-41%) UUP(-15%) UNG(-13%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.255% (StdDev 4.51%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-20.58(-542.11%) | Resistance Level | $5.84 | 5 Day Moving Average | $4.65(0.11%) | 10 Day Moving Average | $5.14(-9.44%) | 20 Day Moving Average | $5.84(-20.29%) | To recent high | -35% | To recent low | 2.5% | Market Cap | $385m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |